Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.
A five-year prospective study of cutaneous leishmaniasis in an endemic area of Brazil revealed an annual incidence of disease of 8.1 per 1000 inhabitants and a prevalence of 14.9%. The disease fluctuated as a series of mini-epidemics. Most disease occurred in individuals who were 10-30 years of age. Mucosal disease occurred in 2.7% of patients with primary lesions and occurred a median of six years after this lesion. Disease was more common in males, in those with either large or multiple antecedent skin lesions, and in those with incomplete antimony therapy for the primary lesions. An ELISA was positive in 85% of those tested during the first two years after the primary lesion and remained positive for five to 40 years in 27% of patients. Skin testing was positive in 96% of patients with recent lesions and remained positive in 70% of patients. All patients with mucosal disease had positive serological and skin tests.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000818:Animals; D000906:Antibodies / Q000032:analysis; D001938:Brazil; D002648:Child; D004199:Disease Vectors; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007897:Leishmaniasis, Mucocutaneous / Q000453:epidemiology* / Q000276:immunology; D008297:Male; D012621:Seasons; D012882:Skin Tests; D013997:Time Factors
D000906:Antibodies